These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12798337)

  • 1. Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.
    Fei X; Zheng QH; Liu X; Wang JQ; Sun HB; Mock BH; Stone KL; Miller KD; Sledge GW; Hutchins GD
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2217-22. PubMed ID: 12798337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
    Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD
    Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents.
    Oltenfreiter R; Staelens L; Labied S; Kersemans V; Frankenne F; Noël A; Van de Wiele C; Slegers G
    Cancer Biother Radiopharm; 2005 Dec; 20(6):639-47. PubMed ID: 16398616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.
    Zheng QH; Fei X; Liu X; Wang JQ; Bin Sun H; Mock BH; Lee Stone K; Martinez TD; Miller KD; Sledge GW; Hutchins GD
    Nucl Med Biol; 2002 Oct; 29(7):761-70. PubMed ID: 12381456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.
    Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.
    O'Brien PM; Ortwine DF; Pavlovsky AG; Picard JA; Sliskovic DR; Roth BD; Dyer RD; Johnson LL; Man CF; Hallak H
    J Med Chem; 2000 Jan; 43(2):156-66. PubMed ID: 10649971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of an array of potential matrix metalloproteinase inhibitors using a sequence of polymer-supported reagents.
    Caldarelli M; Habermann J; Ley SV
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2049-52. PubMed ID: 10450979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.
    Tamura Y; Watanabe F; Nakatani T; Yasui K; Fuji M; Komurasaki T; Tsuzuki H; Maekawa R; Yoshioka T; Kawada K; Sugita K; Ohtani M
    J Med Chem; 1998 Feb; 41(4):640-9. PubMed ID: 9484512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.
    Zheng QH; Fei X; Liu X; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Miller KD; Sledge GW; Hutchins GD
    Nucl Med Biol; 2004 Jan; 31(1):77-85. PubMed ID: 14741572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a beta-tetrapeptide analog as a mother compound for the development of matrix metalloproteinase-2-imaging agents.
    Mukai T; Suganuma N; Soejima K; Sasaki J; Yamamoto F; Maeda M
    Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):260-5. PubMed ID: 18310933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.
    Beutel B; Daniliuc CG; Riemann B; Schäfers M; Haufe G
    Bioorg Med Chem; 2016 Feb; 24(4):902-9. PubMed ID: 26810711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents.
    Oltenfreiter R; Staelens L; Hillaert U; Heremans A; Noël A; Frankenne F; Slegers G
    Appl Radiat Isot; 2005 Jun; 62(6):903-13. PubMed ID: 15799868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.
    Oltenfreiter R; Staelens L; Lejeune A; Dumont F; Frankenne F; Foidart JM; Slegers G
    Nucl Med Biol; 2004 May; 31(4):459-68. PubMed ID: 15093816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.
    Levin JI; Gu Y; Nelson FC; Zask A; DiJoseph JF; Sharr MA; Sung A; Jin G; Cowling R; Chanda P; Cosmi S; Hsiao CL; Edris W; Wilhelm J; Killar LM; Skotnicki JS
    Bioorg Med Chem Lett; 2001 Jan; 11(2):239-42. PubMed ID: 11206468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
    Levin JI; Du MT; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Moy FJ; Powers R; Jin G; Cowling R; Skotnicki JS
    Bioorg Med Chem Lett; 2001 Jan; 11(2):235-8. PubMed ID: 11206467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.
    Martin FM; Beckett RP; Bellamy CL; Courtney PF; Davies SJ; Drummond AH; Dodd R; Pratt LM; Patel SR; Ricketts ML; Todd RS; Tuffnell AR; Ward JW; Whittaker M
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2887-92. PubMed ID: 10522712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition.
    Hu Y; Xing L; Thomason JR; Xiang J; Ipek M; Guler S; Li H; Sabatini J; Chockalingam P; Reifenberg E; Sheldon R; Morris EA; Georgiadis KE; Tam S
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6800-3. PubMed ID: 21982494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosynthesis of a ⁶⁸Ga labeled matrix metalloproteinase inhibitor as a potential probe for PET imaging.
    Claesener M; Schober O; Wagner S; Kopka K
    Appl Radiat Isot; 2012 Aug; 70(8):1723-8. PubMed ID: 22750564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.
    Breyholz HJ; Schäfers M; Wagner S; Höltke C; Faust A; Rabeneck H; Levkau B; Schober O; Kopka K
    J Med Chem; 2005 May; 48(9):3400-9. PubMed ID: 15857146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.
    Kopka K; Breyholz HJ; Wagner S; Law MP; Riemann B; Schröer S; Trub M; Guilbert B; Levkau B; Schober O; Schäfers M
    Nucl Med Biol; 2004 Feb; 31(2):257-67. PubMed ID: 15013492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.